| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 84 / 328 | 74th | Q2 |
| Pharmaceutical Science | 50 / 191 | 74th | Q2 |
| Molecular Medicine | 68 / 179 | 62nd | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Profiles of Drug Substances, Excipients and Related Methodology
Profiles of Drug Substances, Excipients and Related Methodology is Scopus-indexed (Q2, CiteScore 6.7). Published by Academic Press Inc..
Checked against the index lists dated .
ISSN 1871-5125Verify ISSN ↗
Publisher: Academic Press Inc.
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Profiles of Drug Substances, Excipients and Related Methodology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2007–present (also 2005, 2001–2003), best quartile Q2, CiteScore 6.7.
What quartile is Profiles of Drug Substances, Excipients and Related Methodology in Scopus?
Profiles of Drug Substances, Excipients and Related Methodology is Q2 in Pharmacology (rank 84 of 328), Q2 in Pharmaceutical Science (rank 50 of 191) and Q2 in Molecular Medicine (rank 68 of 179), by CiteScore 2025.
What is the impact factor of Profiles of Drug Substances, Excipients and Related Methodology?
Profiles of Drug Substances, Excipients and Related Methodology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 6.7, quartile Q2, 74th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Who publishes Profiles of Drug Substances, Excipients and Related Methodology and what is its ISSN?
Profiles of Drug Substances, Excipients and Related Methodology is published by Academic Press Inc. Its ISSN is 1871-5125.
Is Profiles of Drug Substances, Excipients and Related Methodology in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Profiles of Drug Substances, Excipients and Related Methodology open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Profiles of Drug Substances, Excipients and Related Methodology? — open metrics via OpenAlex
Profiles of Drug Substances, Excipients and Related Methodology has an h-index of 34 and a 2-year mean of 0.41 citations per paper (OpenAlex). Its Scopus CiteScore is 6.7, quartile Q2. On 2-year citations it ranks #267 of 319 Scopus journals in Pharmacology.
Profiles of Drug Substances, Excipients and Related Methodology published 11 papers in 2025; its busiest recent year was 2019 with 20. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Profiles of Drug Substances, Excipients and Related Methodology? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.